[ Price : $8.95]
The Trump administration adds a gender ideology statement to two Web pages on draft guidances that FDA was ordered by a federal ju...[ Price : $8.95]
Bristol Myers Squibb says a Phase 3 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for treating patients with completel...[ Price : $8.95]
A Friends of Cancer Research study update says FDA continues to review and approve novel cancer drugs faster than the European Med...[ Price : $8.95]
Sanofi and Johnson & Johnson stop the development of their vaccine candidate for extraintestinal pathogenic E. coli because Phase ...[ Price : $8.95]
The DC District Court rules for FDA in a Vanda Pharmaceuticals lawsuit seeking an agency order to revoke the approval of a Teva AN...[ Price : $8.95]
The Kaiser Permanente healthcare system calls for FDA and congressional changes to improve the utility of the drug accelerated app...[ Price : $8.95]
FDA approves an Astellas Pharma supplemental NDA for Izervay (avacincaptad pegol intravitreal solution) that revises the labeling ...[ Price : $8.95]
A Buchannan Ingersoll petition asks FDA to impose conditions on ANDAs for generic forms of the cancer drug Leukeran.